FDA authorizes boosters for people over 65; Delta Air Lines reports 82% vaccination rate among employees; Catalent strikes deal with Phathom Pharmaceuticals.
Five things for health marketers to know: Thursday, September 23, 2021
Biogen considers layoffs in the wake of Aduhelm launch; Luxturna’s Bennett launches gene therapy company; health officials pressure Moderna to share COVID-19 vaccine technology.
Five things for health marketers to know: Wednesday, September 22, 2021
Pfizer/BioNTech vaccine safe for children aged 5 to 11, companies report; Health officials support FDA’s booster recommendation for older people; David Meek joins Mirati Therapeutics as CEO.
Five things for health marketers to know: Monday, September 20, 2021
U.S. to purchase millions of vaccine doses to donate globally; AstraZeneca explores combination therapies for lung cancer; Italy mandates COVID-19 passes for public and private workers.
Five things for health marketers to know: Friday, September 17, 2021
90% of United Airlines employees fully vaccinated; Amgen’s combination colon cancer treatment shows promising results; Emergent Biosciences makes a $90 million deal with Providence Therapeutics to develop mRNA vaccines.
Five things for health marketers to know: Thursday, September 16, 2021
FDA maintains neutrality on booster shots as decision nears; Moderate Democrats vote against drug pricing proposal in House committee; FDA to review experimental ALS treatment from Amylyx.
Five things for health marketers to know: Wednesday, September 15, 2021
Biden administration mandates federal employees to be vaccinated by Nov. 22; Pfizer vaccine data on children under 5 to be released in October; fourth child dies in Astellas-Audentes gene therapy trial.
Five things for health marketers to know: Tuesday, September 14, 2021